ReviewAdvances in experimental medicine and biology2026
Gonocytes in Transition: Establishing the Male Germline Identity.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male germline development is characterized by a unique perinatal phase in which primordial germ cells (PGCs) differentiate into gonocytes (prospermatogonia) and subsequently give rise to spermatogonia. This chapter outlines the cellular, molecular, and epigenetic programs that orchestrate this transition, establishing the foundation of the lifelong spermatogenic lineage. Gonocytes undergo a transient G0/G1 arrest tightly regulated by retinoic acid (RA) metabolism, CDK inhibition, TGF family signaling, and the RNA-binding protein NANOS2, which integrates somatic cues to suppress meiosis and enforce male fate. Concurrently, gonocytes experience genome-wide de novo DNA methylation driven by NSD1-mediated H3K36me2 deposition and the DNMT3A/DNMT3L/DNMT3C machinery, accompanied by piRNA-directed transposon silencing and paternal imprint establishment. These processes collectively reshape the chromatin landscape and stabilize the male germline epigenome. The subsequent gonocyte-to-spermatogonia transition (GST) involves FGF, GDNF, and RA signaling, as well as dynamic histone demethylation, to generate spermatogonial stem cells (SSCs). Aberrant regulation of these pathways can arrest differentiation and predispose germ cells to transformation, as seen in testicular germ cell tumors (TGCTs), whose precursor cells retain gonocyte-like features. We further discuss the interplay between transposon control, imprinting, and chromatin architecture that underpins gonocyte identity. Emerging single-cell and small-input omics approaches are now redefining this transient developmental state, providing new insight into how epigenetic reprogramming and signaling convergence establish the male germline.
Indexed as
Identifiers
42455434What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.